![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to si... Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402. Show more
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (โRezoluteโ or the โCompanyโ), a late-stageย biopharmaceutical company committed to developing novel, transformative...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (โRezoluteโ or the โCompanyโ), a late-stageย biopharmaceutical company committed to developing novel, transformative...
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (โRezoluteโ or the โCompanyโ), a late-stageย biopharmaceutical company committed to developing novel, transformative...
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (โRezoluteโ or the โCompanyโ), a late-stageย biopharmaceutical company committed to developing novel, transformative...
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (โRezoluteโ or the โCompanyโ), a clinical-stageย biopharmaceutical company committed to developing novel...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.24 | 5.42986425339 | 4.42 | 4.9 | 4.38 | 203402 | 4.62877415 | CS |
4 | 0.65 | 16.2094763092 | 4.01 | 5.1199 | 4.01 | 279475 | 4.46925347 | CS |
12 | 1.6 | 52.2875816993 | 3.06 | 6.0999 | 2.48 | 703401 | 3.79111869 | CS |
26 | 3.46 | 288.333333333 | 1.2 | 6.0999 | 0.9199 | 520441 | 3.07578893 | CS |
52 | 2.84 | 156.043956044 | 1.82 | 6.0999 | 0.72 | 287376 | 2.86965181 | CS |
156 | -5.15 | -52.49745158 | 9.81 | 11.7499 | 0.72 | 142457 | 3.13523083 | CS |
260 | -15.48 | -76.8619662363 | 20.14 | 21.2 | 0.72 | 121045 | 3.52177815 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions